Welcome : Guest

Sophiris Bio, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Sophiris Bio, Inc., which is principally involved in Clinical-Stage Biopharmaceuticals Business. Illustrated with 21 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-60243
Price: $1050
Company Type: Public
Pages: 23
Date: November 2016
Market Data Tables: 21

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Cancer Market......3
Table 1: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others......3
Table 2: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......4
Cancer Patients......5
Table 3: No. of Cancer Patients by Type in the US (2015) - Percentage Market Share Breakdown for Colorectal Cancer (CRC), Melanoma, Non-Squamous Non-Small-Cell Lung Cancer (NSCLC), Ovarian, Prostate, Renal Cell Carcinoma (RCC), and Squamous Non-Small-Cell Lung Cancer (NSCLC)......5
Table 4: Number of Cancer Patients by Type in the US (2015) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......6
Table 5: No. of Cancer Patients Death by Type in the US (2015) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......7
Table 6: Number of Cancer Patients by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix Uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......8
Table 7: No. of Solid Cancer Tumor Patients by Type Worldwide (2015) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......9
Prescription to Over-the-Counter ( Rx- to-OTC)......10
Table 8: Prescription to Over-the-Counter ( Rx- to-OTC) Switch Market by Product Category in the US (2015) - Percentage Share Breakdown by Value for Benign Prostatic Hyperplasia, Erectile Dysfunction, Migraines, Nasal Sprays, Ophthalmics, Over Active Bladder, Statins, and Others (Asthma, Omega-3)......10
Urology Market......11
Table 9: Urology Market by Product Segment Worldwide (2015) - Percentage Breakdown by Value for Basic Drainage, Catheter Stabilization, Continence, Temperature Management, and Urological Specialties......11
Table 10: Urology Care Market by Region Worldwide (2015) - Percentage Share Breakdown for Europe, North America, and Rest of World (RoW)......12
Table 11: Urology Market by Category in North America and Europe (2015) - Percentage Share Breakdown by Value for Erectile Dysfunction, Gynaecological Pain, Hypogonadism, Interstitial Cystitis/Painful Bladder Syndrome, Premature Ejaculation, Urinary Incontinence, and Urological Cancers......13
Table 12: Urology and Gynaecology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Dialysis Equipment, Gynaecology Devices, Urinary Catheters, and Urology Devices......14
Urinary Incontinence......15
Table 13: Urinary Continence Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Americas, Europe, and Rest of World......15
Table 14: Prevalence of Urinary Incontinence by Gender in the US (2015) - Percentage Share Breakdown for Men and Women......16
Table 15: Prevalence of Urinary Incontinence in Women (Age Group (>60)) by Type in the US (2015) - Percentage Share Breakdown for Did Not Experience, and Experience......17
Table 16: Prevalence of Urinary Incontinence in Women (Age Group (18-44)) by Type in the US (2015) - Percentage Share Breakdown for Did Not Experience, and Experience......18
Urinary Incontinence Drugs......19
Table 17: Urinary Incontinence Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anticholinergic Agents, and Newer Therapies......19
Table 18: Urinary Incontinence Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Detrol, Detrol LA (PFE), Newer Therapies (ACT, AGN, PFE), Oxybutinin, and Others (Generics)......20
Overactive Bladder (OAB)......21
Table 19: Prevalence of Overactive Bladder (OAB) in Men (Age >18) by Type in the US (2015) - Percentage Market Share Breakdown for Did Not Experience, and Experience......21
Table 20: Prevalence of Overactive Bladder (OAB) in Women (Age >18) by Type in the US (2015) - Percentage Market Share Breakdown for Did Not Experience, and Experience......22
Urinary Incontinence Therapeutics......23
Table 21: Market Shares of Leading Urinary Incontinence Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Eli Lilly and Company, Johnson & Johnson, Novartis AG, Pfizer, Inc., and Others......23